Members of the previous forum can retrieve their temporary password here, (login and check your PM).

SSRI and Sigma-1 receptor agonist Fluvoxamine mitigates COVID-19

Thread starter dithyramb
Start date Oct 31, 2021

Migrated topic.

dithyramb

Established member

Senior Member

Oct 31, 2021

Frontiers | Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

Fluvoxamine is a well-tolerated, widely available, inexpensive selective serotonin reuptake inhibitor that has been shown in a small, double-blind, placebo-c...

www.frontiersin.org

Facebook X (Twitter) Reddit Pinterest Tumblr WhatsApp Email Link

Science and Philosophy
Science

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.

Accept Learn more…

Back

Top Bottom